1. Home
  2. EVOK vs GRNQ Comparison

EVOK vs GRNQ Comparison

Compare EVOK & GRNQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVOK
  • GRNQ
  • Stock Information
  • Founded
  • EVOK 2007
  • GRNQ 2013
  • Country
  • EVOK United States
  • GRNQ Malaysia
  • Employees
  • EVOK N/A
  • GRNQ N/A
  • Industry
  • EVOK Biotechnology: Pharmaceutical Preparations
  • GRNQ EDP Services
  • Sector
  • EVOK Health Care
  • GRNQ Technology
  • Exchange
  • EVOK Nasdaq
  • GRNQ Nasdaq
  • Market Cap
  • EVOK 7.1M
  • GRNQ 8.9M
  • IPO Year
  • EVOK 2013
  • GRNQ 2018
  • Fundamental
  • Price
  • EVOK $4.81
  • GRNQ $1.08
  • Analyst Decision
  • EVOK
  • GRNQ
  • Analyst Count
  • EVOK 0
  • GRNQ 0
  • Target Price
  • EVOK N/A
  • GRNQ N/A
  • AVG Volume (30 Days)
  • EVOK 10.0K
  • GRNQ 327.5K
  • Earning Date
  • EVOK 03-13-2025
  • GRNQ 03-27-2025
  • Dividend Yield
  • EVOK N/A
  • GRNQ N/A
  • EPS Growth
  • EVOK N/A
  • GRNQ N/A
  • EPS
  • EVOK N/A
  • GRNQ N/A
  • Revenue
  • EVOK $8,617,036.00
  • GRNQ $2,727,344.00
  • Revenue This Year
  • EVOK $97.35
  • GRNQ N/A
  • Revenue Next Year
  • EVOK $99.52
  • GRNQ N/A
  • P/E Ratio
  • EVOK N/A
  • GRNQ N/A
  • Revenue Growth
  • EVOK 100.35
  • GRNQ N/A
  • 52 Week Low
  • EVOK $3.54
  • GRNQ $0.80
  • 52 Week High
  • EVOK $12.32
  • GRNQ $2.24
  • Technical
  • Relative Strength Index (RSI)
  • EVOK 59.77
  • GRNQ 50.02
  • Support Level
  • EVOK $4.68
  • GRNQ $0.97
  • Resistance Level
  • EVOK $4.94
  • GRNQ $1.28
  • Average True Range (ATR)
  • EVOK 0.28
  • GRNQ 0.07
  • MACD
  • EVOK 0.06
  • GRNQ -0.00
  • Stochastic Oscillator
  • EVOK 73.58
  • GRNQ 60.42

About EVOK Evoke Pharma Inc.

Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.

About GRNQ Greenpro Capital Corp.

Greenpro Capital Corp operates and provides business solution services to small and medium-sized businesses located in Southeast Asia and East Asia, with a focus on Hong Kong, China and Malaysia, and in Thailand and Taiwan. Its range of services includes cross-border business solutions, record management services, and accounting outsourcing services. Cross-border business services include other services, tax planning, trust and wealth management, cross-border listing advisory services, and transaction services. It also operates a venture capital business. Its segments include Service business engaged in the provision of corporate advisory and business solution services; and Real estate business engaged in trading or leasing of commercial real estate properties in Hong Kong and Malaysia.

Share on Social Networks: